We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PENN icon
301
PENN Entertainment
PENN
$2.69B
$40.1M 0.06%
464,481
+53,102
+13% +$3.79M
PAYC icon
302
Paycom
PAYC
$10.1B
$40.1M 0.06%
88,654
-2,651
-3% -$1.06M
ROKU icon
303
Roku
ROKU
$22.3B
$39.9M 0.06%
120,277
-1,761
-1% -$462K
ETSY icon
304
Etsy
ETSY
$7.55B
$39.9M 0.06%
224,048
+9,468
+4% +$1.42M
AJG icon
305
Arthur J. Gallagher & Co
AJG
$64.5B
$39.6M 0.05%
319,711
+7,370
+2% +$839K
LH icon
306
Labcorp
LH
$25.7B
$39.5M 0.05%
226,014
+304
+0.1% +$52.5K
PPL
307
PPL Corp
PPL
$26B
$38.8M 0.05%
1,374,892
-113,060
-8% -$3.21M
MTCH icon
308
Match Group
MTCH
$8.4B
$38.5M 0.05%
254,479
-61
-0% -$8.07K
TECH icon
309
Bio-Techne
TECH
$11.2B
$38.4M 0.05%
483,260
-14,896
-3% -$1.08M
CGNX icon
310
Cognex
CGNX
$11.3B
$37.7M 0.05%
470,070
-11,063
-2% -$804K
OMC icon
311
Omnicom Group
OMC
$22.6B
$37.5M 0.05%
601,738
+9,311
+2% +$532K
GNRC icon
312
Generac Holdings
GNRC
$12.5B
$37.4M 0.05%
164,670
-4,880
-3% -$1.05M
IP icon
313
International Paper
IP
$21.5B
$37.3M 0.05%
791,250
+4,020
+0.5% +$180K
HOLX
314
DELISTED
Hologic
HOLX
$37.2M 0.05%
510,227
-16,250
-3% -$1.15M
LEN icon
315
Lennar Class A
LEN
$20.4B
$37.1M 0.05%
502,250
+1,003
+0.2% +$75.1K
MASI
316
DELISTED
Masimo
MASI
$37M 0.05%
137,754
-3,449
-2% -$860K
TTD icon
317
Trade Desk
TTD
$8.31B
$36.9M 0.05%
460,550
-8,480
-2% -$640K
INCY icon
318
Incyte
INCY
$24B
$36.8M 0.05%
423,084
+6,088
+1% +$527K
CAH icon
319
Cardinal Health
CAH
$55.7B
$36.7M 0.05%
685,408
+11,122
+2% +$577K
FTV icon
320
Fortive
FTV
$18.4B
$36.7M 0.05%
686,943
-124,618
-15% -$6.41M
ZBRA icon
321
Zebra Technologies
ZBRA
$17.2B
$36.6M 0.05%
95,197
-2,639
-3% -$888K
CBRE icon
322
CBRE Group
CBRE
$42.7B
$36.6M 0.05%
582,917
-58,059
-9% -$3.28M
CDW icon
323
CDW
CDW
$17.7B
$36.5M 0.05%
277,169
-5,107
-2% -$669K
PARA
324
DELISTED
Paramount Global Class B
PARA
$36.2M 0.05%
972,694
+36,015
+4% +$1.16M
HRL icon
325
Hormel Foods
HRL
$13.8B
$36.1M 0.05%
775,105
-64,803
-8% -$3.16M

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.